Alan Kozikowski
Net worth: 436 545 $ as of 2024-04-29
Profile
Alan P.
Kozikowski was the founder of Actuate Therapeutics, Inc. (founded in 2015) and Bright Minds Biosciences, Inc. (founded in 2019), where he held the title of Director in 2022.
He was the President & Chief Executive Officer of Starwise Therapeutics LLC from 2017 to 2020.
He also held the title of Director-Drug Discovery Program at Georgetown University Medical Center and was a Professor at the University of Pittsburgh.
From 2013 to 2017, he was a Professor-Emeritus at the University of Illinois.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-21 | 400,500 ( 9.27% ) | 436 545 $ | 2024-04-29 |
Former positions of Alan Kozikowski
| Companies | Position | End |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Founder | 2022-09-06 |
| Starwise Therapeutics LLC | Chief Executive Officer | 2020-01-31 |
| University of Illinois | Corporate Officer/Principal | 2017-07-30 |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Founder | - |
| Georgetown University Medical Center | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Private companies | 2 |
|---|---|
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
| Starwise Therapeutics LLC |
- Stock Market
- Insiders
- Alan Kozikowski
